Profound Medical (TSE:PRN) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Profound Medical Corp. has successfully closed a $40.25 million public offering of common shares, with the funds aimed at boosting the commercialization of their TULSA-PRO and Sonalleve systems. The offering saw strong interest with the full exercise of the over-allotment option, highlighting investor confidence in Profound Medical’s innovative medical device technologies.
For further insights into TSE:PRN stock, check out TipRanks’ Stock Analysis page.
